FDC Ltd.
Snapshot View

View in App

Prices View details >>

255.30 -0.90 ▼-0.4%

31 March 2023, 04:01:00 PM
Volume: 6,158

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.fdcindia.com
Market Cap 4,256.42 Cr.
Enterprise Value(EV) 4,237.04 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 10.47 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 24.38 Trailing Twelve Months Ending 2022-12
Industry PE 32.41 Trailing Twelve Months Ending 2022-12
Book Value / Share 127.76 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.00 Calculated using Price: 255.30
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 16.59 Cr. 165,910,084 Shares
FaceValue 1
Company Profile
FDC Limited is among India's leading fully integrated pharmaceutical companies. The Company is a pioneer in the manufacture of specialised formulations, and among the world's foremost manufacturers and marketers of Oral Rehydration Salts (ORS). Over its long history of 85 years, the Company has maintained a distinguished reputation for high-quality, affordable products and built a market-leading brand portfolio.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.35%
1 Week
+0.24%
1 Month
-2.78%
3 Month
-5.97%
6 Month
-3.37%
1 Year
-0.62%
2 Year
-10.64%
5 Year
+1.41%
10 Year
+177.05%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 16.63 16.64 16.72 16.03 13.63 12.48 16.03 18.36 11.71
Return on Capital Employed (%) 27.12 23.02 23.11 21.51 19.00 17.49 21.56 23.74 15.78
Return on Assets (%) 13.26 13.34 13.97 12.00 9.03 8.20 10.43 11.85 7.59

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 845 936 1,082 1,270 1,276 1,445 1,547 1,734 1,957 1,901
Non Curr. Liab. 31 24 20 217 211 229 315 300 391 33
Curr. Liab. 196 188 163 389 480 497 565 622 690 365
Minority Int. 0 0 0
Equity & Liab. 1,072 1,148 1,266 1,876 1,968 2,172 2,427 2,655 3,038 2,297
Non Curr. Assets 619 646 742 958 977 1,113 1,181 1,303 1,620 1,281
Curr. Assets 452 502 523 918 991 1,058 1,245 1,352 1,418 1,016
Misc. Exp. not W/O 0
Total Assets 1,072 1,148 1,266 1,876 1,968 2,172 2,427 2,655 3,038 2,297

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 846 889 994 1,014 1,075 1,091 1,344 1,333 1,528 1,690
Other Income 42 46 39 50 51 43 69 97 76 60
Total Income 888 935 1,033 1,064 1,126 1,134 1,413 1,430 1,604 1,750
Total Expenditure -641 -691 -766 -770 -848 -860 -1,051 -999 -1,274 -1,476
PBIDT 246 244 268 294 278 274 362 431 330 274
Interest -3 -2 -1 -1 -1 -1 -3 -3 -3 -4
Depreciation -25 -39 -34 -35 -35 -33 -37 -38 -37 -38
Taxation -83 -56 -63 -63 -67 -67 -80 -87 -73 -58
Exceptional Items -6 -1 -2
PAT 135 148 169 189 174 170 240 301 216 174
Minority Interest 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 135 148 169 189 174 170 240 301 216 174
Adjusted EPS 8 8 9 11 10 10 14 18 13 10

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 150 150 128 174 154 150 112 250 207 162
Cash Fr. Inv. -107 -55 -89 -73 -144 20 -120 -98 -77 -145
Cash Fr. Finan. -63 -75 -48 -97 0 -169 0 -142 -129 -10
Net Change -20 19 -9 4 11 1 -8 10 1 7
Cash & Cash Eqvt 4 23 15 16 27 28 20 30 30 38

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 69.35 69.35 69.35 69.35 69.36 69.36 69.50 69.49 69.49
Public 30.65 30.65 30.65 30.65 30.64 30.64 30.51 30.51 30.51
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 30 Mar 2023
Closure of Trading Window
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 & Amendments thereon and in compliance with Companys Code of Conduct for the Prevention of Insider Trading and Code of Fair Disclosure the Trading Window for dealing in Securities of the Company for all the Designated Persons Connected Persons and their Immediate Relative(s) shall remain closed from Saturday April 01 2023 until 48 hours after the declaration of the Audited Financial Results of the Company for the quarter and year ended March 31 2023.The date of Board Meeting of the Company for consideration and approval of the Audited Financial Results for the quarter and year ended March 31 2023 will be intimated in duecourse.
Mon, 27 Mar 2023
US - FDA Inspection At Company'S Manufacturing Facility Located At Roha Dist.- Raigad Maharashtra India.
This is to inform you that our manufacturing unit located at Roha Dist.- Raigad Maharashtra that manufactures Active Pharmaceutical Ingredient (APIs) products has been inspected by US FDA from 20th March 2023 to 24th March 2023. The said audit has been successfully completed by the US FDA with No observations (Zero 483s). The Active Pharmaceutical Ingredients (APIs) product manufactured at the above facility continues to be marketed in USA.
Mon, 13 Feb 2023
US - FDA Inspection At Company'S Manufacturing Facility Located At Waluj Aurangabad.
This is to inform you that our manufacturing plant located at B-8 MIDC Industrial Area Waluj Aurangabad Maharashtra which manufactures sterile ophthalmic products has been inspected by US FDA from 06th February to 12th February 2023. The said audit has been successfully completed by the US FDA with No observations (Zero 483s). The audit was carried out for the sterile ophthalmic products being marketed inthe US.

Technical Scans View Details >>

Fri, 31 Mar 2023
High Delivery Percentage High Delivery Percentage
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Closing Near 20 SMA Closing Near 20 SMA
CCI Trending Up CCI Trending Up
Wed, 29 Mar 2023
High Delivery Percentage High Delivery Percentage

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,878.62 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. 76,960.86 4,624.15 +1.3%
Divi's Laboratories Ltd. 75,014.78 2,826.00 +0.3%
Cipla Ltd. 72,696.02 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. 61,962.56 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. 52,030.91 1,543.40 +0.2%
Zydus Lifesciences Ltd. 49,749.83 491.00 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.00 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 21.13 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 31.30 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 27.55 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.03 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.86 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.11 491.00 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.26 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 6.03 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 3.20 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.04 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.19 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 491.00 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 491.00 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 491.00 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 491.00 +0.1%

FAQ's On FDC Ltd.

What is FDC share price?
Can I buy FDC shares now?
What is the Market Cap of FDC?
What are the key metrics to analyse FDC?
What is the 52 Week High and Low of FDC?
What is the trend of FDC share price?